359 results on '"Horowitz, Netanel A."'
Search Results
52. Hematopoietic Cell Transplantation in Adult Acute Lymphoblastic Leukemia
53. An update on the management of hematologic malignancies in pregnancy
54. Histamine dihydrochloride for maintaining remission in acute myeloid leukemia
55. Bortezomib-induced peripheral neuropathy is related to altered levels of brain-derived neurotrophic factor in the peripheral blood of patients with multiple myeloma
56. Disseminated NK-T Cell Lymphoma Initially Suspected by the Presence of Circulating CD45 bright/CD7 negative NK cells
57. Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: A prospective controlled trial
58. Trajectories of Key Physiological Parameters in COVID-19 Patients Using Continuous Remote Monitoring and Health AI
59. Bortezomib Maintenance Therapy as a Standard of Care Provides Favorable Outcomes in Newly Diagnosed Myeloma Patients: A Multisite Real-Life Study
60. Recovery from SARS-CoV-2 infection is associated with serum BDNF restoration
61. Thrombosis and Hemostasis Issues in Cancer Patients with COVID-19
62. Thrombosis in hematological malignancies: mechanisms and implications
63. Brain‐derived neurotrophic factor as a potential biomarker of chemotherapy‐induced peripheral neuropathy and prognosis in haematological malignancies; what we have learned, the challenges and a need for global standardization
64. CpG methylation in cell-free Epstein-Barr virus DNA in patients with EBV-Hodgkin lymphoma
65. Flow cytometry aneuploidy and cell cycle indexing as a possible tool for differentiating between CD10 + diffuse large B‐cell lymphoma and follicular lymphoma
66. Myeloid-Derived Suppressor Cells As Potential Contributors to Pregnancy-Associated Lymphoma Progression
67. Clinical Characteristics, Treatment Patterns and Outcomes of Solitary Plasmacytoma - a Multicenter Retrospective Cohort Study
68. Bone marrow blast elimination by the fifth day of 7 + 3 induction is the strongest predictor of potential cure in patients with acute myeloid leukemia younger than 61 years of age: A long‐term follow‐up of a multi‐center prospective study
69. Outcomes of Post-Induction Bortezomib Therapy in Patients with Newly diagnosed Multiple Myeloma: A Multi-Center Retrospective Observational Study
70. Characteristics, management and outcome of DLBCL patients, presenting with simultaneous systemic and CNS disease at diagnosis: A retrospective multicenter study
71. 577-P: Increased Symptoms of Peripheral Neuropathy and Depression in Insulin-Treated Type 2 Diabetic Patients Are Associated with Reduced BDNF Serum Protein Levels and Val66Met-SNP
72. Advances in BCR/ABL positive ALL
73. Addition of high-dose methotrexate to standard treatment for patients with high-risk diffuse large B-cell lymphoma contributes to improved freedom from progression and survival but does not prevent central nervous system relapse
74. Prediction of Chemotherapy-Induced Peripheral Neuropathy in Patients with Lymphoma and Myeloma: the Roles of Brain-Derived Neurotropic Factor Protein Levels and A Gene Polymorphism
75. Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
76. Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial
77. Published abstracts at international meetings often over- or underestimate the initial response rate
78. Rambam Health Care Campus Research Day Organizing Committee
79. Flow cytometry aneuploidy and cell cycle indexing as a possible tool for differentiating between CD10+ diffuse large B‐cell lymphoma and follicular lymphoma.
80. Romidepsin treatment for relapsed or refractory peripheral and cutaneous T-cell lymphoma: Real-life data from a national multicenter observational study.
81. Advances in the genetics of acute lymphoblastic leukemia in adults and the potential clinical implications
82. Brain derived neurotropic factor single nucleotide polymorphism Val66Met and serum protein levels are associated with development of vincristine‐induced peripheral neuropathy in patients with lymphoma
83. Composite splenic marginal zone lymphoma and mantle cell lymphoma with p53 deletion and tetraploidization
84. BST-236, a Novel Cytarabine Pro-Drug, Enables Safe and Effective Administration of High Dose Cytarabine to Older or Unfit Patients with Acute Leukemia. Results of a Phase I/II Study
85. Diffuse Large B Cell Lymphoma Mimicking Granulomatosis with Polyangiitis
86. Treatment and prognosis of stage I follicular lymphoma in the modern era – does PET matter?
87. Acute myeloid leukemia during pregnancy: a systematic review and meta-analysis
88. Beac and BEAM High-Dose Chemotherapy in Patients with Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation Are Efficacious, with Comparable Toxicity
89. Astarabine, a Novel Leukemia-Targeted Cytarabine Composition Allows, for the First Time, the Delivery of High Cytarabine Doses for Older or Unfit Patients with Acute Leukemia. Results of an Ongoing Phase I/IIa Study
90. Primary Plasma Cell Leukemia Has a Poor Prognosis Even in the Era of Novel Agents - a Multicenter Case Series
91. Can We Improve the Predictive Value of Interim PET/CT Using a New Prognostic Model for Advanced Hodgkin Lymphoma?
92. Addition of Intermediate-Dose Methotrexate Is Beneficial in Terms of Both Progression-Free Survival and Overall Survival for Patients with Diffuse Large B Cell Lymphoma Receiving Either R-CHOP or CHOP
93. TLR9-Regulated IL10 Mediates Immune Inhibitory Activity of Chronic Lymphocytic Leukemia B-Cells
94. Flow cytometry aneuploidy and cell cycle indexing as a possible tool for differentiating between CD10+diffuse large B‐cell lymphoma and follicular lymphoma
95. Mosunetuzumab and Polatuzumab Vedotin Demonstrates Preliminary Efficacy in Elderly Unfit/Frail Patients with Previously Untreated Diffuse Large B-Cell Lymphoma
96. Efficacy and Safety of Glofitamab in Patients with R/R DLBCL in Real Life Setting - a Retrospective Study
97. Haematological malignancies in pregnancy: An overview with an emphasis on thrombotic risks
98. Bone marrow blast elimination by the fifth day of 7 + 3 induction is the strongest predictor of potential cure in patients with acute myeloid leukemia younger than 61 years of age: A long‐term follow‐up of a multi‐center prospective study
99. Different Sources of Stromal Cells Diversely Affect Survival and Trafficking of Mantle Cell Lymphoma Cells
100. Treating Indolent Lymphoma in Older Adults: What Is the Right Way?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.